$-0.02
(Market cap
$99 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.3
-
Face value
--
-
Shares outstanding
67,164,801
10 Years Aggregate
CFO
$-112.12 Mln
EBITDA
$-138.24 Mln
Net Profit
$-27.42 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Microbot Medical (MBOT)
| -26.5 | -14.5 | -27.6 | -61.4 | -12.4 | -28.0 | -39.2 |
|
BSE Sensex
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Microbot Medical (MBOT)
| 78.6 | -31.5 | -45.5 | -59.9 | 8.9 | -32.3 | 491.3 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Microbot Medical (MBOT)
|
1.5 | 99.4 | 0.4 | -16.3 | -4,722.3 | -22.3 | -- | 1.5 |
| 82.7 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 260.3 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 71.4 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 56.9 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 107.7 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 363.8 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 538.7 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 583.2 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 353.4 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Microbot Medical (MBOT)
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical... system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts Read more
-
Co-Founder, President, CEO & Chairman
Mr. Harel Gadot
-
Co-Founder, President, CEO & Chairman
Mr. Harel Gadot
-
Headquarters
Hingham, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Microbot Medical (MBOT)
What is the current share price of Microbot Medical Inc (MBOT) Today?
The share price of Microbot Medical Inc (MBOT) is $1.47 (NASDAQ) as of 01-Sep-2026 16:00 EDT. Microbot Medical Inc (MBOT) has given a return of -12.44% in the last 3 years.
What is the current PB & PE ratio of Microbot Medical Inc (MBOT)?
Since, TTM earnings of Microbot Medical Inc (MBOT) is negative, P/E ratio is not available.
The P/B ratio of Microbot Medical Inc (MBOT) is 1.46 times as on 28-Aug-2026, a 72 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-10.22 |
1.73 |
2024 |
-1.67 |
5.40 |
2023 |
-1.85 |
4.42 |
2022 |
-1.76 |
3.19 |
2021 |
-4.71 |
3.71 |
What is the 52 Week High and Low of Microbot Medical Inc (MBOT)?
The 52-week high and low of Microbot Medical Inc (MBOT) are Rs 4.67 and Rs 1.44 as of 02-Sep-2026.
What is the market cap of Microbot Medical Inc (MBOT)?
Microbot Medical Inc (MBOT) has a market capitalisation of $ 99 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Microbot Medical Inc (MBOT)?
Before investing in Microbot Medical Inc (MBOT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.